Anzahl der Einträge: 9.
2022
Winkler, René ,
Mägdefrau, Ann-Sophie,
Piskor, Eva-Maria,
Kleemann, Markus,
Beyer, Mandy,
Linke, Kevin,
Hansen, Lisa,
Schaffer, Anna-Maria ,
Hoffmann, Marina E. ,
Poepsel, Simon ,
Heyd, Florian,
Beli, Petra,
Möröy, Tarik,
Mahboobi, Siavosh,
Krämer, Oliver H. und
Kosan, Christian
(2022)
Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition.
Oncogene 41 (40), S. 4560-4572.
Beyer, Mandy,
Henninger, Sven J.,
Haehnel, Patricia S.,
Mustafa, Al-Hassan M. ,
Gurdal, Ece ,
Schubert, Bastian,
Christmann, Markus,
Sellmer, Andreas ,
Mahboobi, Siavosh,
Drube, Sebastian,
Sippl, Wolfgang,
Kindler, Thomas und
Krämer, Oliver H.
(2022)
Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells.
Cell Chemical Biology 29 (3), 398-411.e4.
Volltext nicht vorhanden.
2021
Wachholz, Vanessa,
Mustafa, Al-Hassan M.,
Zeyn, Yanira,
Henninger, Sven J.,
Beyer, Mandy,
Dzulko, Melanie,
Piée-Staffa, Andrea,
Brachetti, Christina,
Haehnel, Patricia S.,
Sellmer, Andreas,
Mahboobi, Siavosh,
Kindler, Thomas,
Brenner, Walburgis,
Nikolova, Teodora und
Krämer, Oliver H.
(2021)
Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3.
Archives of Toxicology 96 (1), S. 177-193.
2020
Sellmer, Andreas,
Pilsl, Bernadette,
Beyer, Mandy,
Pongratz, Herwig,
Wirth, Lukas,
Elz, Sigurd,
Dove, Stefan,
Henninger, Sven Julian,
Spiekermann, Karsten,
Polzer, Harald,
Klaeger, Susan,
Kuster, Bernhard,
Böhmer, Frank D.,
Fiebig, Heinz-Herbert,
Krämer, Oliver H. und
Mahboobi, Siavosh
(2020)
A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia.
European Journal of Medicinal Chemistry 193, S. 112232.
Volltext nicht vorhanden.
2018
Leonhardt, Michel,
Sellmer, Andreas ,
Krämer, Oliver H.,
Dove, Stefan,
Elz, Sigurd,
Kraus, Birgit,
Beyer, Mandy und
Mahboobi, Siavosh
(2018)
Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
European Journal of Medicinal Chemistry 152, S. 329-357.
Volltext nicht vorhanden.
Sellmer, Andreas,
Stangl, Hubert,
Beyer, Mandy,
Grünstein, Elisabeth,
Leonhardt, Michel,
Pongratz, Herwig,
Eichhorn, Emerich,
Elz, Sigurd,
Striegl, Birgit,
Jenei-Lanzl, Zsuzsa,
Dove, Stefan,
Straub, Rainer H.,
Krämer, Oliver H. und
Mahboobi, Siavosh
(2018)
Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors.
Journal of Medicinal Chemistry 61 (8), S. 3454-3477.
Volltext nicht vorhanden.
2017
Noack, Katrin,
Mahendrarajah, Nisintha,
Hennig, Dorle,
Schmidt, Luisa,
Grebien, Florian ,
Hildebrand, Dagmar,
Christmann, Markus,
Kaina, Bernd,
Sellmer, Andreas,
Mahboobi, Siavosh,
Kubatzky, Katharina,
Heinzel, Thorsten und
Krämer, Oliver H.
(2017)
Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells.
Archives of Toxicology 91 (5), S. 2191-2208.
Volltext nicht vorhanden.
Schäfer, Claudia,
Göder, Anja,
Beyer, Mandy,
Kiweler, Nicole,
Mahendrarajah, Nisintha,
Rauch, Anke,
Nikolova, Teodora,
Stojanovic, Natasa,
Wieczorek, Martin,
Reich, Thomas R.,
Tomicic, Maja T.,
Linnebacher, Michael,
Sonnemann, Jürgen,
Dietrich, Sascha,
Sellmer, Andreas,
Mahboobi, Siavosh,
Heinzel, Thorsten,
Schneider, Günter und
Krämer, Oliver H.
(2017)
Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells.
Cellular Signalling 29, S. 218-225.
Volltext nicht vorhanden.
Mahendrarajah, Nisintha,
Borisova, Marina E.,
Reichardt, Sigrid,
Godmann, Maren,
Sellmer, Andreas,
Mahboobi, Siavosh,
Haitel, Andrea,
Schmid, Katharina,
Kenner, Lukas ,
Heinzel, Thorsten,
Beli, Petra und
Krämer, Oliver H.
(2017)
HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3.
Cellular Signalling 39, S. 9-17.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Thu Nov 21 14:25:59 2024 CET.